57 results
SC 13E3/A
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
(together with any amendments and supplements thereto, the “Letter of Transmittal”), which, together with any other related materials, as each may
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
of such written request and materials, the Rights Agent will, subject to its reasonable determination that the transfer instrument is in proper form … and materials delivery, postage and handling.
The fees quoted in this schedule apply to record keeping services provided by the Rights Agent
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
30 May 23
Tender offer solicitation (amended)
9:42pm
materials, to review the status of the transaction with the Company’s management and its legal and financial advisors. At the meeting, representatives
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
24 May 23
Tender offer solicitation (amended)
9:40pm
. Houlihan Lokey has consented to the use of its materials in this Schedule 14D-9.”
The following bullet point is added under the heading “Purpose
CORRESP
STSA
Satsuma Pharmaceuticals Inc
24 May 23
Correspondence with SEC
12:00am
prior written consent.” Please disclose in the Schedule 14D-9, if true, that Houlihan Lokey has consented to the use of its materials in the filing
UPLOAD
pthq9n3oy1cw
23 May 23
Letter from SEC
12:00am
SC 14D9
wvt9mbwpb6921u62kl
5 May 23
Tender offer solicitation
8:17am
SC 14D9
EX-99
ekg6qr636mooss vvkqs
5 May 23
Tender offer solicitation
8:17am
SC14D9C
6ev91tks58z4 7zqg
17 Apr 23
Written communication relating to third party tender offer
4:02pm
8-K
EX-99.1
v3cxkp5tbxo7ejg 1sxt
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
367pqt6l106th2febq
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-10.1
07wn35q
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
kiut0vceoz 8k
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
SC TO-C
EX-99.2
ho86t 8lta7a
17 Apr 23
Information about tender offer
6:08am
SC TO-C
EX-99.1
twa yd3lb9aqjj
17 Apr 23
Information about tender offer
6:08am
8-K
f6t dd5lidsq
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
8-K
wvlgoza0
14 Nov 22
Satsuma Pharmaceuticals Announces Topline Results from SUMMIT Phase
4:04pm
8-K
EX-1.1
vc4xt5z0 w7mb62eh
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
ye5nzubw2rg
3 Nov 22
Prospectus supplement for primary offering
4:42pm